Pharma
Better market access
Discover our latest thinking on pricing and market access to navigate complexity, maximize value, and unlock better market access.
Life Science insights
For 40+ years, Simon-Kucher has helped healthcare companies unlock growth by commercializing innovation, strengthening value propositions, and improving patient outcomes.
Better Health
At Simon-Kucher, we believe in better health - Our latest Better Health Report, developed in partnership with AESGP, explores how manufacturers can better support pharmac
Most Favored Nation (MFN)
Discover our latest thinking on Most Favored Nation (MFN) pricing to assess global implications, navigate uncertainty, and unlock better market access.
CDMO growth outlook for 2025
More healthcare insights
No results. Please try your search again.
